University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Sirolimus tablets

Post-transplant pre 2015

Status: Amber Sodium zirconium cyclosilicate (Lokelma®)

Amber specialist initiation with RICaD

Status: Red Solriamfetol (Sunosi®)
Status: Amber Somatrogon (Ngenla®)
Status: Amber Somatropin injection
Status: Red Sorafenib tablets

National CDF list. Negative outcome - CDF funded.

Status: Red Sotrovimab (Xevudy®)
Status: Red Streptokinase injection

Hospital use only

Status: Red Sunitinib capsules

Hospital use only

Status: Amber Tacrolimus 0.03% ointment (30g)

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top